<div id="readability-page-1"><div>WELL Health Releases CEO Letter to Shareholders WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the release of a letter to shareholders from its Founder, Chairman and Chief Executive Officer, Hamed Shahbazi, outlining the Company’s strategic priorities for 2026 and the principles guiding its next phase of growth. The CEO letter can be accessed from the Company’s website at: https://well.company/CEOLetter/ WELL HEALTH TECHNOLOGIES CORP. Per: “Hamed Shahbazi” Hamed Shahbazi Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp. WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 43,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 240 clinics supporting primary care, specialized care, and diagnostic services. In the United States, WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company. Forward-Looking Statements This news release, and associated letter, may contain “Forward-Looking Information” within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the Company’s strategies and growth plans; expectations regarding subsidiaries and future divestitures; expected year over year returns; and the ability to generate free cash flow. Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-Looking Information involve known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance. WELL’s comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL ‘s control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; that future results may vary from historical results; inability to obtain any requisite future financing on suitable terms; any inability to realize the expected benefits and synergies of acquisitions; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.com, including its most recent Annual Information Form. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMjE4Njk2MzVyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMjE4Njk2MzVyMQ"/> For further information: Tyler Baba Investor Relations, Manager investor@well.company 604-628-7266 View source version on businesswire.com: https://www.businesswire.com/news/home/20260121869635/en/</div></div>

XWEL

標普醫療保健服務 ETF - SPDR

醫療業 ETF - SPDR

美國醫療保健供應商 ETF - iShares

WELL

醫療業 ETF - Vanguard

標普全球醫療股指數 ETF - iShares

WELL Health Technologies Corp. 發佈了首席執行官 Hamed Shahbazi 致股東的信，概述了公司在 2026 年的戰略優先事項和增長原則。WELL 專注於利用技術提升醫療保健成果，支持北美超過 43,000 名醫療服務提供者。信中強調了公司賦能醫療從業者和通過創新解決方案改善患者結果的使命。信中還包含了關於公司戰略和潛在風險的前瞻性聲明，突顯了醫療行業的不確定性

WELL Health 發佈了首席執行官致股東的信函